BLB&B Advisors’s Diebold Nixdorf Incorporated DBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-21,300
Closed -$641K 278
2015
Q4
$641K Sell
21,300
-1,100
-5% -$37.4K 0.14% 138
2015
Q3
$667K Buy
22,400
+1,248
+6% +$40.6K 0.15% 129
2015
Q2
$740K Buy
21,152
+2,230
+12% +$78.7K 0.15% 125
2015
Q1
$671K Buy
18,922
+1,100
+6% +$37.1K 0.14% 129
2014
Q4
$617K Buy
17,822
+470
+3% +$16.6K 0.13% 134
2014
Q3
$613K Buy
17,352
+700
+4% +$26.4K 0.13% 141
2014
Q2
$669K Buy
16,652
+100
+0.6% +$3.84K 0.14% 140
2014
Q1
$660K Buy
+16,552
New +$596K 0.15% 141

Other funds holding DBD

BLB&B Advisors's DBD Position: Q1 2016 in Review

BLB&B Advisors sold out of Diebold Nixdorf Incorporated (DBD) in Q1 2016, closing a stake of 21,300 shares — an estimated $641K sold.

BLB&B Advisors first reported a position in DBD in Q1 2014 and held it in 8 quarters. The position peaked at $740K in Q2 2015. 217 funds tracked by Wall St. Rank hold DBD as of Q1 2016.

  • BLB&B Advisors reported no remaining Diebold Nixdorf Incorporated position as of Q1 2016 after selling out during the quarter.
  • BLB&B Advisors sold 21,300 Diebold Nixdorf Incorporated shares in Q1 2016, an estimated $641K.
  • BLB&B Advisors first reported a position in Diebold Nixdorf Incorporated in Q1 2014 and held it in 8 quarters.
  • BLB&B Advisors's Diebold Nixdorf Incorporated position peaked at $740K in Q2 2015.
  • 217 funds tracked by Wall St. Rank held Diebold Nixdorf Incorporated as of Q1 2016.

Based on BLB&B Advisors's 13F filing for Q1 2016, filed 18 Apr 2016.